Musculoskeletal Recovery Through MLS Laser Therapy Protocols

Musculoskeletal Recovery Through MLS Laser Therapy

Abstract

In this educational post, I, Dr. Alexander (Alex) Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, explain how light-based therapies—specifically photobiomodulation therapy (PBMT), commonly known as low-level laser therapy—enhance cellular healing, reduce pain, and accelerate functional recovery for musculoskeletal and neuropathic conditions. I translate the basic science into practical clinical protocols and connect PBMT to mitochondrial activation, redox balance, cytokine modulation, vascular and neural repair, and connective tissue remodeling. I also show how PBMT synergizes with platelet-rich plasma (PRP) and other orthobiologics to move care from symptom suppression to genuine tissue repair.

This care model operates within a multidisciplinary, integrative setting. Our practice, Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, is directed medically by Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). Dr. Cardenas serves as Medical Director and Collaborative Physician, working alongside me to coordinate chiropractic care, internal medicine oversight, functional medicine, personal injury care, and rehabilitation services. Together we combine evidence-based chiropractic methods with PBMT, orthobiologics, precision diagnostics, and progressive rehab to restore patient function safely and effectively.

What follows is a clear, step-by-step guide through the physiological underpinnings, research highlights from leading groups, clinical observations from our practice, and rationale for how and why integrative chiropractic care fits within PBMT-centered treatment plans.

My Clinical Journey into Light-Based Healing

I have spent nearly a decade advancing light-based care in a musculoskeletal and functional medicine environment. Early on, discussing “laser” in conservative musculoskeletal medicine drew skepticism. Yet as our understanding of cellular bioenergetics matured, the link between light, mitochondria, and tissue healing became difficult to ignore.

• We evolved under the sun; our cells possess light-sensitive chromophores. The most important mitochondrial photoacceptor in the near-infrared (NIR) range appears to be cytochrome c oxidase (complex IV), which can absorb photons and alter mitochondrial signaling.
• Just as we accept sunlight’s role in vitamin D synthesis, a growing evidence base supports the role of photobiomodulation in modulating cellular metabolism and gene expression to promote repair.

Our team has progressively integrated PBMT into orthopedic, chiropractic, and rehabilitation protocols because it consistently helps patients transition from acute inflammation to resolution and tissue rebuilding.

Defining Photobiomodulation Therapy: The Cellular Logic

• Photo = light, bio = life, modulation = adjust or influence. PBMT uses specific red-to-near-infrared wavelengths to deliver non-thermal photons that are absorbed by cellular chromophores, thereby triggering metabolic, redox, and transcriptional cascades.

What makes this clinically powerful is not that PBMT “treats tennis elbow” or “treats knee osteoarthritis” in a one-to-one fashion, but that it treats the cellular environment underlying those conditions. We aim to shift a pathologic microenvironment (hypoxia, oxidative stress, inflammatory signaling) toward a pro-reparative state.

Key mechanisms:

• Mitochondrial activation: Absorption of red/NIR photons by cytochrome c oxidase can displace inhibitory nitric oxide at complex IV, enhance electron transport, and increase ATP production, while modulating reactive oxygen species (ROS) as signaling molecules (Hamblin, 2016).
• Redox signaling: Low, transient elevations of ROS serve as second messengers that engage transcription factors (e.g., NF-κB, Nrf2), leading to downstream changes in gene expression with anti-inflammatory, antioxidant, and pro-repair outcomes (Salehpour et al., 2019).
• Nitric oxide (NO) and microcirculation: PBMT supports vasodilation, angiogenesis, and microvascular perfusion, which improves oxygen and nutrient delivery and waste removal (Farivar et al., 2014).
• Cytokine modulation: PBMT tends to upregulate anti-inflammatory cytokines (e.g., IL-10) while downregulating pro-inflammatory cytokines (e.g., IL-6), moving tissues from an inflamed to a reparative phase (Aimbire et al., 2006; Vale et al., 2009).
• Tissue-specific effects:
  • Neurogenesis and axonal support with growth cone guidance and neurotrophic signaling (Salehpour et al., 2019).
  • Myocellular recovery with improved mitochondrial density and myoglobin expression supporting oxygen handling.
  • Fibroblast proliferation and collagen remodeling for connective tissue healing.
  • Tenocyte proliferation in tendon environments, aligning with preliminary bench and translational observations.

The clinical net effect: better pain control, faster functional recovery, and stronger tissue resilience.

Light, Depth, and Dose: Why Wavelengths Matter

To be effective, photons must reach target tissues without being excessively absorbed or scattered by:

• Skin
• Blood
• Water

This is why the therapeutic optical window—roughly 600–1200 nm—is crucial. Red light (~600–700 nm) benefits superficial tissues (skin, superficial fascia), while near-infrared (~800–980 nm and beyond) penetrates deeper into muscle, tendon, joint capsules, and peripheral nerves (Anders et al., 2015).

• Red light: Great for skin and near-surface tissues; typical penetration is a few millimeters.
• Near-infrared (NIR): Better for deeper MSK targets; may penetrate centimeters depending on anatomical site and device parameters.

Dose is defined by fluence (J/cm²), irradiance (mW/cm²), wavelength, emission mode (continuous vs. pulsed), and treatment time. The response often follows a biphasic dose curve—too little energy yields no effect; too much may attenuate benefits. This is why our clinic uses protocols that standardize and personalize dosing based on tissue depth, body habitus, and condition acuity.

From Inflammation to Repair: Cytokines, Vessels, Nerves, and Connective Tissue

PBMT helps “unstick” stalled inflammatory states (for example, chronic tendinopathies with thickened, hypovascular tissue) by shifting cytokine profiles and optimizing perfusion. Mechanistic snapshots:

• Cytokines and immune cells
  • Upregulation of IL-10 supports inflammation resolution.
  • Downregulation of IL-6 and other pro-inflammatory mediators reduces catabolic signaling (Aimbire et al., 2006; Vale et al., 2009).
  • Mast cell and neutrophil activity shifts toward controlled, reparative engagement.
• Angiogenesis and microcirculation
  • Increases in factors such as VEGF and other pro-angiogenic signals promote capillary growth and endothelial function, thereby improving oxygenation and nutrient delivery (Farivar et al., 2014).
• Neural repair and pain modulation
  • Enhanced axon growth and neurotrophin signaling; mitigation of neuroinflammation that underlies neuropathic pain (Salehpour et al., 2019).
  • Descending inhibition and peripheral nociceptor modulation create multimodal analgesia without opioids.
• Muscle recovery
  • Improved mitochondrial efficiency and myoglobin support better oxidative capacity, faster recovery from microtrauma, and reduced delayed-onset soreness.
• Fibroblasts and tenocytes
  • Increased proliferation and matrix synthesis under appropriate dosing; better collagen alignment and tensile properties during remodeling.
  • These changes are consistent with emerging bench data demonstrating dose-dependent proliferation of tendon cells under PBMT, and they align with our clinical outcomes in chronic tendinopathies.

Clinical Applications in Sports, Surgery, and Chronic Conditions

In a Division I sports context and high-volume musculoskeletal practice, we use PBMT to:

• Acute sports injuries: Apply PBMT within hours to days to control edema, reduce pain, and accelerate return to play by improving microcirculation and cellular energy.
• Postoperative recovery: Treat surgical sites to attenuate iatrogenic inflammation, reduce bruising/ecchymosis, and support incision quality and comfort. Patient-reported outcomes indicate greater satisfaction and faster functional milestones.
• Chronic tendinopathies and arthropathies: Combine PBMT with corrective loading, fascial work, and, where indicated, orthobiologics to shift recalcitrant tissues into an active remodeling phase.

These results parallel a growing body of literature. There are several thousand publications collectively supporting the benefits of PBMT across applications in pain, inflammation, wound healing, oral surgery, neurology, and ophthalmology (Anders et al., 2015; Hamblin, 2016; Salehpour et al., 2019). Furthermore, national policy discussions increasingly recognize PBMT as a non-opioid pain management tool.

Integrating Chiropractic Care with Internal Medicine Oversight

Our model is intentionally multidisciplinary. Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, working closely with me and our team.

• Medical direction and safety
  • Dr. Cardenas oversees medical appropriateness, screens for comorbidities (e.g., metabolic syndrome, vascular disease), and coordinates medication management, including careful tapering of analgesics when appropriate.
  • She integrates laboratory and cardiometabolic assessments to optimize systemic healing variables (glucose control, lipid status, micronutrients, inflammatory markers).
• Chiropractic integration
  • I provide evidence-based spinal and extremity adjustments, soft-tissue and fascial mobilization, and regional interdependence strategies to normalize biomechanics, reduce aberrant load, and facilitate lymphatic and venous return.
  • PBMT is layered onto this care to optimize the cellular response in the very tissues we are mechanically addressing.
• Functional medicine
  • We deploy nutrition, mitochondrial cofactors, sleep optimization, and stress modulation to elevate tissue healing, leveraging synergistic effects with PBMT. Redox support (e.g., NAC, alpha-lipoic acid when indicated), omega-3s, and polyphenols can complement PBMT’s anti-inflammatory signaling, under Dr. Cardenas’s oversight.
• Rehabilitation and personal injury care
  • We tailor graded exposure and progressive loading strategies to match the tissue’s biological readiness, as indicated by pain, swelling, and functional measures.
  • In personal injury cases, PBMT helps shorten the window of disability by accelerating tissue normalization, as documented by objective measures and validated patient-reported outcomes.

This MD-chiropractic-functional medicine framework ensures that light-based modalities are deployed safely, precisely, and in harmony with each patient’s mechanical and metabolic realities.

Why Integrative Chiropractic Care Fits PBMT

Chiropractic care is, at its core, a biomechanical and neurophysiological intervention. PBMT is a bioenergetic and biochemical intervention. When combined:

• Load correction + bioenergetic activation: Adjustments, soft-tissue work, and corrective exercise reduce pathological loads while PBMT energizes cells to remodel tissues effectively.
• Neurophysiologic synergy: Manual therapies modulate segmental and central processing, while PBMT decreases peripheral nociception and neuroinflammation, together producing robust analgesia and improved motor control.
• Timing and dosing: We often precondition tissues with PBMT before manual therapy to reduce guarding and after sessions to minimize post-treatment soreness and reinforce anabolic signaling.

My clinical observations, published insights, and practice posts (see dralexjimenez.com and my LinkedIn) have consistently highlighted this synergy: when we honor both mechanics and metabolism, recovery strengthens and stabilizes.

References to my clinical reflections:

• Jimenez, A. (n.d.). Clinical observations and insights. Retrieved from https://dralexjimenez.com/
• Jimenez, A. (n.d.). Professional updates and case reflections. Retrieved from https://www.linkedin.com/in/dralexjimenez/

Orthobiologics and PBMT: Building Synergy for Better Outcomes

Orthobiologics such as platelet-rich plasma (PRP) deliver growth factors and anti-inflammatory proteins that instruct cells to repair. PBMT provides the energy and signaling milieu for those instructions to be executed efficiently:

• Mitochondrial ATP supports protein synthesis, cytoskeletal remodeling, and matrix assembly triggered by PRP.
• Improved perfusion increases delivery of platelets, oxygen, and nutrients.
• Cytokine balance tilts toward resolution, decreasing matrix catabolism.

Veterinary randomized trials—useful because animals lack secondary gain—have shown that combining PBMT with PRP in osteoarthritis yields superior outcomes compared to either alone, with owners documenting functional improvements in stairs, car entry, and gait. These findings align with human registry observations in which patients receiving PBMT plus orthobiologics report greater pain reductions and functional gains at follow-ups through 6–12 months.

Mechanistically, this pairing makes sense: messaging (PRP) + energy (PBMT) strengthens the cell’s capacity to carry out the repair program.

Device Considerations: Safety, Emission Modes, and Practical Delivery

In practice, emission mode matters. Synchronous multiwavelength systems that deliver both continuous and pulsed NIR light allow us to:

• Control thermal load on the skin while delivering sufficient fluence to deeper tissues.
• Use pulsed frequencies to support photochemical signaling without overheating, enabling unattended protocols in a busy clinic with strong safety margins.

Key clinical considerations:

• Targeting: We map treatment to the tissue’s depth and shape, adjusting grid size, dwell time, and energy density.
• Scheduling:
  • Acute injuries: brief, more frequent sessions in the first 1–2 weeks.
  • Chronic conditions: steady cadence over 4–8 weeks with reassessment at predefined milestones.
• Outcome tracking: We use validated tools (e.g., NPRS/VAS, ODI/NDI, LEFS/QuickDASH), functional tests, and tissue-specific measures (range of motion, tendon palpation tenderness, hop tests, grip strength) to titrate care.

From Symptom Control to Disease Modification

The aim is to intervene earlier and more precisely:

• Identify biomechanical faults and correct them before chronic degeneration sets in.
• Use PBMT and functional medicine to optimize mitochondrial health and redox tone, creating a healing-permissive environment.
• When necessary, add orthobiologics to promote anabolism in tendons, ligaments, and joints.

By addressing both mechanics and cellular metabolism, we reduce the need for late-stage procedures and improve quality of life sooner.

How We Build a PBMT-Centered Care Plan

1. Assessment and stratification
   • MD evaluation by Dr. Cardenas for comorbidities, medication interactions, and lab baselines (e.g., HbA1c, hsCRP, vitamin D, lipid panel).
   • Chiropractic-biomechanical assessment for segmental and regional dysfunction, load faults, and motor control issues.
   • Functional screening and outcome baselines.
2. Initial interventions
   • PBMT dosing tailored to tissue depth.
   • Gentle manual therapy and neuromotor activation to normalize mechanics.
   • Early lifestyle and nutrition support to prime healing.
3. Progressive rehabilitation
   • Load progression and mechanotransduction principles based on tissue response.
   • Ongoing PBMT to maintain anti-inflammatory signaling and mitochondrial support.
4. Adjunct orthobiologics as needed
   • PRP or other orthobiologics when indicated by tissue status and patient goals.
   • PBMT timed pre- and post-injection to enhance cellular uptake and post-procedural comfort.
5. Reassessment and maintenance
   • Validate progress with functional outcomes and imaging when appropriate.
   • Transition to self-care with periodic PBMT boosts during high-load phases.

Example Use Cases from Practice

• Acute lateral ankle sprain
  • Early PBMT reduces edema and pain; tissue gliding improves, allowing faster initiation of proprioception and strengthening.
  • Return-to-play metrics improve, with fewer setbacks during the ramp-up.
• Post-arthroscopic shoulder repair
  • PBMT decreases ecchymosis and postoperative pain, reducing reliance on opioids.
  • Patients report better sleep and earlier participation in controlled ROM protocols.
• Chronic mid-portion Achilles tendinopathy
  • PBMT attenuates neurogenic inflammation and supports tenocyte activity.
  • Combined with eccentric and isometric loading, tissue thickening and pain decline while function increases.

Each protocol is overseen within our integrative framework, with Dr. Cardenas coordinating systemic medical factors and my team executing biomechanical and photobiomodulation strategies.

Evidence Highlights and Evolving Research

The PBMT literature spans basic science, animal models, and human clinical trials. Key synthesis points:

• Mitochondrial photobiology and clinical translation are extensively reviewed (Hamblin, 2016; Salehpour et al., 2019).
• Clinical guidelines and consensus statements are increasingly acknowledging PBMT for musculoskeletal pain, facilitating its role in non-opioid strategies.
• Research in neurology (including trials on depression and Parkinson’s disease) underscores the systemic relevance of photobiomodulation beyond MSK care.
• Registries and practice-based evidence suggest durable gains in pain and function when PBMT is integrated with manual care and rehabilitation, with additive benefits when used alongside orthobiologics.

Our clinic continues to document outcomes and participate in data-sharing initiatives to strengthen the evidence base and refine dosing by phenotype and condition.

Why This Matters Now

As of 2026-05-02, healthcare continues to pivot toward multimodal, non-opioid pain management and precision rehabilitation. PBMT offers:

• A low-risk, non-pharmacologic method to accelerate tissue repair.
• Compatibility with chiropractic, physical therapy, orthobiologics, and internal medicine.
• A route to move beyond symptomatic relief toward true disease modification in musculoskeletal care.

By integrating PBMT into a coherent plan that addresses mechanics, metabolism, and medical comorbidities, we help patients heal faster and more completely.

About Our Team and How We Work

• Medical Director: Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933).
• Chiropractic and Functional Medicine Lead: Dr. Alexander (Alex) Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST.
• Clinic: Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), El Paso, Texas.

We operate a patient-centered, multidisciplinary model that emphasizes evidence-based chiropractic, medical oversight, functional medicine, photobiomodulation, and progressive rehabilitation. Our goal is clear: reduce pain, restore function, and empower durable recovery.

References

• Aimbire, F., Albertini, R., Pacheco, M. T. T., Castro-Faria-Neto, H. C., & de Oliveira, A. P. (2006). Low-level laser therapy induces dose-dependent reduction of TNF-α levels in acute inflammation. Lasers in Surgery and Medicine, 38(10), 853–859.
• Anders, J. J., Wu, X., & Kiranyaz, S. (2015). Low level light/laser therapy versus photobiomodulation therapy. Photobiomodulation, Photomedicine, and Laser Surgery, 33(4), 183–184.
• Farivar, S., Malekshahabi, T., & Shiari, R. (2014). Biological effects of low level laser therapy. Lasers in Medical Science, 29(2), 659–666.
• Hamblin, M. R. (2016). Shining light on the head: Photobiomodulation for brain disorders. BBA Clinical, 6, 113–124.
• Salehpour, F., Rasta, S. H., Hamblin, M. R., & Cassano, P. (2019). The potential of transcranial photobiomodulation therapy for major depressive disorder: A systematic review. Lasers in Medical Science, 34(2), 351–366.
• Vale, M. L., et al. (2009). Anti-inflammatory and analgesic effects of low-level laser therapy on zymosan-induced arthritis. Journal of Photochemistry and Photobiology B: Biology, 93(2), 82–89.